イソニアジドによる潜在性結核治療の肝障害

DOI Web Site PubMed 被引用文献2件 参考文献20件

書誌事項

タイトル別名
  • LIVER DAMAGE IN TREATMENT OF LATENT TUBERCULOUS INFECTION BY ISONIAZID
  • イソニアジド ニ ヨル センザイセイ ケッカク チリョウ ノ カン ショウガイ

この論文をさがす

抄録

[Purpose] To study the frequency and degree of liver damage as adverse effect of isoniazid (INH) preventive therapy in Japanese people.<BR>[Object and Metho d] Chart review of Japanese persons who started isoniazid preventive chemotherapy in the two clinics in Tokyo, from 2003/1/1 to 2004/12/31.<BR>[Result] There were 77 9 cases who did not transiently or completely stop INH preventive therapy because of adverse effect, and 26 cases who stopped INH transiently or completely because of liver damage as adverse effect (total 805 cases). In 371 cases, of those 779 cases, AST (asparate aminotransferase) and ALT (alanine aminotransferase) was measured after starting INH at least once. In 14. 9% (59/397) of these 391 cases ( =371 + 26), liver damage as adverse effect was found. In 1. 51 % (6/397), liver damage with AST and/or ALT higher than 400 11U/L was found. Clinical hepatitis, associated with clinical symptom of hepatitis, was seen in 0. 37% (3/805). Hepatitis with liver failure was seen in 0. 12%. There was no death due to liver damage.<BR>[Conclusion] Li ver damage as adverse effect of isoniazid (INH) preventive therapy in Japanese people is not rare.

収録刊行物

  • 結核

    結核 81 (11), 651-660, 2006

    一般社団法人 日本結核病学会

被引用文献 (2)*注記

もっと見る

参考文献 (20)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ